ELIZABETH DRY: Open Payments
NPI 1790317022 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,062 in 106 payments from 21 companies in 2025. Trend: 2023 $3,507 · 2024 $2,157 · 2025 $2,062
Food & beverage: $2,062
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $349 |
| PFIZER INC. | 10 | $245 |
| AstraZeneca Pharmaceuticals LP | 12 | $234 |
| Amgen Inc. | 15 | $169 |
| GlaxoSmithKline, LLC. | 9 | $161 |
| Lilly USA, LLC | 7 | $160 |
| ABBVIE INC. | 7 | $143 |
| Phathom Pharmaceuticals, Inc. | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Dexcom, Inc. | 3 | $68 |
Products named: Ozempic, AIRSUPRA, Wegovy, NURTEC ODT, OTEZLA, VOQUEZNA, ELIQUIS, LEQVIO.
Industry payments across FL — which companies pay providers there.
